Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
December 11, 2025 13:30 ET | Source: Merakris Therapeutics

Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, announces that...
December 10, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
December 10, 2025 06:00 ET | Source: SANUWAVE Health, Inc.

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 08, 2025 06:00 ET | Source: SANUWAVE Health, Inc.

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
November 25, 2025 08:59 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Expands Product Access in Medicaid

BioStem Technologies Expands Product Access in Medicaid
November 13, 2025 16:02 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Third Quarter 2025 Financial Results

BioStem Technologies Reports Third Quarter 2025 Financial Results
November 13, 2025 16:01 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Announces Filing of Restated Financial Statements

BioStem Technologies Announces Filing of Restated Financial Statements
November 07, 2025 06:00 ET | Source: SANUWAVE Health, Inc.

Sanuwave Announces Q3 FY2025 Financial Results

Sanuwave Announces Q3 FY2025 Financial Results
November 05, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes